People receiving cancer treatment need integrated care to manage heart failure risk
06 July 2022
The Heart Failure Policy Network (HFPN) has launched Spotlight on cancer treatment and heart failure, which highlights the need for integrated care and collaboration between oncology and cardiology services.
The Heart Failure Policy Network is made possible with financial support from AstraZeneca, Vifor Pharma, Bayer AG and Boehringer Ingelheim. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.